Dabur Pharma sets up US subsidiary

Our Corporate Bureau
09 May 2007

Mumbai: Dabur Pharma has set up a marketing subsidiary company for direct sale of cancer treatment drugs in the US.

The setting up of the new company follows suspension of sales and distribution agreement with Hospira Inc on 5 May.

Dabur Pharma terminated the sales and distribution agreement between Dabur Oncology Plc and Hospira Inc for exclusive supply of oncology (cancer) products in the US, the company said in a filing with the Bombay Stock Exchange (BSE).

"Going forward, the company will sell and distribute its entire range of oncology products in US through its own infrastructure," the release said.

Dabur Oncology Plc, a wholly owned subsidiary of Dabur Pharma in UK, has incorporated the US subsidiary company for marketing oncology products, Dabur Pharma said in its release.